Elliot M. Frohman
University of California, San Francisco
Drug repositioningPathologyDermatologyIntensive care medicineStage (cooking)PediatricsImmunologyMedical historyOverlap syndromeMyelitisPerivascular spaceDendritic cellThyroiditisMHC class IIDiseaseMEDLINECerebrospinal fluidContext (language use)Multiple sclerosisProgressive multifocal leukoencephalopathyGlucocerebrosidaseAtaxiaNatalizumabFamily historyDISEASE RELAPSECase conferenceNeurology clinicCoronavirus disease 2019 (COVID-19)Clinical courseImmune effectsOccultGeneticsAntigen-presenting cellMedicineEncephalitisPandemic
4Publications
1H-index
159Citations
Publications 4
Newest
Abstract The COVID-19 pandemic has devastated individuals, families, and institutions throughout the world. Despite the breakneck speed of vaccine development, the human population remains at risk of further devastation. The decision to not become vaccinated, the protracted rollout of available vaccine, vaccine failure, mutational forms of the SARS virus, which may exhibit mounting resistance to our molecular strike at only one form of the viral family, and the rapid ability of the virus(es) to ...
Source
#1Nidhiben Anadani (UR: University of Rochester)
#2Megan HylandH-Index: 5
Last. Teresa Frohman (UR: University of Rochester)H-Index: 1
view all 16 authors...
A 38-year-old woman with MS receiving natalizumab presented to the neurology clinic with the complaint of a new neurologic symptom. ### Clinical course The patient had a 6-year history of clinically stable MS, albeit exhibiting radiographic progression despite strict adherence to daily
Source
#2Petra D. CravensH-Index: 2
#3Mahendra SinghH-Index: 22
Last. Nancy L. MonsonH-Index: 37
view all 11 authors...
#1Maria del Pilar Martin (University of Texas at Austin)H-Index: 5
#2Petra D. Cravens (University of Texas at Austin)H-Index: 2
Last. Olaf StüveH-Index: 70
view all 12 authors...
Objective To extend our studies on the prolonged and differential effect of natalizumab on T lymphocyte numbers in the cerebrospinal fluid, we investigated the number and phenotypes of leukocytes and the expression of major histocompatibility complex (MHC) classes I and II in cerebral perivascular spaces (CPVS). We hypothesized that natalizumab reduces the number of antigen presenting cells in CPVS. Design A case-control study in which inflammatory cell numbers in the CPVS of cerebral tissue wer...
Source
Close Researchers
Petra D. Cravens
H-index : 2
Raytheon
Michael K. Racke
H-index : 75
Quest Diagnostics
Scott S. Zamvil
H-index : 66
University of California, San Francisco
Bette K. Kleinschmidt-DeMasters
H-index : 75
University of Colorado Denver
Bernhard Hemmer
H-index : 91
Technische Universität München
Todd N. Eagar
H-index : 29
Houston Methodist Hospital
J. Theodore Phillips
H-index : 28
Baylor University
Gina Remington
H-index : 16
University of Texas Southwestern Medical Center
Michael J. Olek
H-index : 22
Loma Linda University
Ryan C. Winger
H-index : 13
University of California, San Francisco
Michael K. Racke
H-index : 10
The Ohio State University Wexner Medical Center
Robert P. Lisak
Grand Canyon University
Thomas Varkey
Stanford University
Scott S. Zamvil
University of California, San Diego
Neda Zarghami Esfanhani
H-index : 1
Kaiser Permanente
Andrew Goodman
H-index : 1
Wayne State University
Olaf Stuve
H-index : 8
University of Düsseldorf
Teresa C. Frohman
Stanford University
Jennifer S. Graves
H-index : 1
University of Rochester
Teresa Frohman
H-index : 1
University of Rochester
Bernhard Hemmer
H-index : 9
University of Ulm
Cole Maguire
H-index : 1
University of California, San Francisco
Martin S. Weber
H-index : 24
Technische Universität München
Maria del Pilar Martin
H-index : 5
University of Texas Southwestern Medical Center
Mahendra Singh
H-index : 22
Indian Institute of Technology Roorkee
Nancy L. Monson
H-index : 37
University of Texas Southwestern Medical Center
Annette Wundes
H-index : 12
University of Washington
Esther Melamed
H-index : 9
University of Texas at Austin
Scott D. Newsome
H-index : 27
Johns Hopkins University
Olaf Stüve
H-index : 70
University of Texas Southwestern Medical Center
Wei Hu
H-index : 12
University of Texas Southwestern Medical Center
Nidhiben Anadani
University of Rochester
Andrew D. Goodman
H-index : 55
University of Rochester Medical Center
Nitin J. Karandikar
H-index : 38
University of Iowa
Kathleen Costello
H-index : 8
National Multiple Sclerosis Society
Yasir Jassam
University of Rochester
Ethan Meltzer
University of Rochester
Scott Newsome
H-index : 1
University of Texas at Austin
Eugene O. Major
H-index : 1
University of Texas at Austin
Robert P. Lisak
H-index : 1
University of Rochester
Matthew S. Parsons
H-index : 2
University of Rochester
Thomas C. Varkey
H-index : 2
University of Texas at Austin
Roberto Alejandro Cruz
H-index : 4
University of Texas at Austin
Megan Hyland
H-index : 5
University of Rochester Medical Center
This website uses cookies.
We use cookies to improve your online experience. By continuing to use our website we assume you agree to the placement of these cookies.
To learn more, you can find in our Privacy Policy.